| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-06 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |